Cargando…
Repurposing strategies on pyridazinone-based series by pharmacophore- and structure-driven screening
We report here in silico repurposing studies on 52 new pyridazinone-based small-molecules through inverse virtual screening (iVS) methodologies. These analogues were originally designed as formyl peptide receptor (FPR) ligands. As it is sometimes the case in drug discovery programmes, subsequent bio...
Autores principales: | Floresta, Giuseppe, Crocetti, Letizia, Giovannoni, Maria Paola, Biagini, Pierfrancesco, Cilibrizzi, Agostino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241479/ https://www.ncbi.nlm.nih.gov/pubmed/32367744 http://dx.doi.org/10.1080/14756366.2020.1760261 |
Ejemplares similares
-
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
por: Crocetti, Letizia, et al.
Publicado: (2022) -
Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity
por: Cantini, Niccolo, et al.
Publicado: (2022) -
Editorial: Serine protease inhibitors and their therapeutic applications
por: Crocetti, Letizia, et al.
Publicado: (2022) -
iVS analysis to evaluate the impact of scaffold diversity in the binding to cellular targets relevant in cancer
por: Cilibrizzi, Agostino, et al.
Publicado: (2018) -
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition
por: Crocetti, Letizia, et al.
Publicado: (2022)